Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ishares Neuroscience and Healthcare ETF (IBRN)

Ishares Neuroscience and Healthcare ETF (IBRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 3,877,100
  • Shares Outstanding, K 150
  • 60-Month Beta 1.36
  • Price/Earnings ttm 28.31
  • Annual Dividend & Yield 0.01 (0.02%)
  • Most Recent Dividend 0.006 on 12/20/23
  • Management Fee 0.47%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.65 +1.35%
on 11/18/24
28.74 -9.55%
on 11/11/24
-1.63 (-5.89%)
since 10/18/24
3-Month
24.07 +7.99%
on 09/11/24
28.74 -9.55%
on 11/11/24
+0.11 (+0.43%)
since 08/20/24
52-Week
20.90 +24.37%
on 11/21/23
28.74 -9.55%
on 11/11/24
+5.00 (+23.80%)
since 11/20/23

Most Recent Stories

More News
What Are Wall Street Analysts' Target Price for Lennar Stock?

Lennar has significantly outperformed the broader market over the past year, yet analysts are moderately bullish on the stock's outlook.

LEN : 168.23 (-0.31%)
$SPX : 5,917.11 (unch)
ITB : 117.50 (+0.19%)
IBRN : 25.99 (+0.85%)
WFC : 73.58 (+0.20%)
Is Wall Street Bullish or Bearish on Biogen Stock?

Despite Biogen’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.

BIIB : 156.00 (+0.37%)
$SPX : 5,917.11 (unch)
IBRN : 25.99 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

See More

Key Turning Points

3rd Resistance Point 26.11
2nd Resistance Point 26.05
1st Resistance Point 26.02
Last Price 25.99
1st Support Level 25.94
2nd Support Level 25.88
3rd Support Level 25.85

See More

52-Week High 28.74
Last Price 25.99
Fibonacci 61.8% 25.75
Fibonacci 50% 24.82
Fibonacci 38.2% 23.90
52-Week Low 20.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar